Pharmacy-mediated substitution of biosimilars - a global survey benchmarking country substitution policies

Larkin, H; Macdonald, J; Lumsden, R

Lumsden, R (reprint author), Pfizer Ltd, Pfizer Essential Hlth Regulatory Affairs, EM Regulatory Policy, Walton Oaks KT20 7NS, Surrey, England.

GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2017; 6 (4): 157